First PIPAC in Brazil
Clinical and scientific basis for the development of CarcinoCheck.
Carcinocheck is a patient management system for oncology, a comprehensive software solution designed to streamline and enhance the care of oncology patients.
Carcinocheck is an innovative startup focused on providing patient management solutions for oncology. Our system helps streamline and enhance patient care by offering comprehensive and intuitive tools for healthcare professionals. With a commitment to medical excellence and technological innovation, we are leading the way to a better future in oncology care management.
Three pillars: Science & Product · International Recognition · National Recognition
Clinical and scientific basis for the development of CarcinoCheck.
April/2022: beginning of hardware and software development.
October/2023: patent filing and definition of the PRO concept.
First autonomous detection.
October/2023: presentation of the CarcinoCheck concept.
1st half/2024: structuring of the beta and creation of annotated datasets.
2nd half/2024: validation (e.g., global Kappa 0.35) and start of Kits 1–3.
December/2024: structuring of the report for peritoneal carcinomatosis.
29/Jul/2024: highlighted in CCT/MCTI (AI Plan 2024–2028).
1st half/2025: regulatory alignment (ANVISA) and product readiness.
2nd half/2025: availability of CarcinoCheck Kits begins.
Feb 8–10, 2025: international participation (08:00–18:00).
2025: presentation of the CarcinoCheck concept.
Scientific consolidation and product evolution.
Global presentation of CarcinoCheck.
Expansion of the ecosystem with Consenticheck and Anestesiocheck.
Expansion to Latin America and Europe.